2 results
Approved WMORecruiting
This study has three specific objectives:1) to explore how the participants* intercorporal bone grafts HU develop over time in the first two years after fusion surgery.2) to explore the interobserver reliability of the HU measurements.3) to explore…
Approved WMOCompleted
To determine if emixustat hydrochloride (emixustat) reduces the rate of progression of macular atrophy (MA) compared to placebo in subjects with Stargardt disease (STGD)1. To evaluate the safety and tolerability of emixustat compared to placebo2. To…